(IN BRIEF) The University of Glasgow is leading the PHOENIX Study, a landmark clinical trial investigating how genetic testing can personalise prescribing across NHS Scotland. Over 4,000 patients will be recruited across Greater Glasgow and Clyde to explore how DNA … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged adverse drug reactions, Agena Bioscience, DNA testing, genetic testing, Katriona Brooksbank, Living Laboratory, medication safety, MyDNA, NHS Greater Glasgow and Clyde, NHS prescribing, personalised medicine, PGx, pharmacogenomics, PHOENIX Study, precision healthcare, Queen Elizabeth University Hospital, Sandosh Padmanabhan, University of Glasgow, West of Scotland Innovation Hub
(IN BRIEF) Wolters Kluwer Health has announced comprehensive updates to its Sentri7 Drug Diversion and Sentri7 Pharmacy solutions, enhancing medication safety and compliance workflows for healthcare teams. The upgraded tools feature more intuitive user interfaces, improved risk scoring, enhanced documentation, … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, Netherlands, News, Technology
Tagged artificial intelligence in healthcare, clinical workflows, cost savings, digital health, Drug Diversion, healthcare compliance, Healthcare Innovation, HEAT score, hospital pharmacy tools, Karen Kobelski, KLAS Research, medication management, medication safety, nursing workflows, opioid crisis, patient safety, pharmacy surveillance, risk management, Sentri7, Sentri7 Pharmacy, Wolters Kluwer
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?